Adeline Sivignon

Clermont-ferrand, 63000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Targeting sialic acid catabolism with polyvalent sialidase inhibitors to mitigate bacterial inflammation in the gut.

Targeting sialic acid catabolism with polyvalent sialidase inhibitors to mitigate bacterial inflammation in the gut.

Journal: Bioorganic chemistry

Published: November 06, 2025

Development of a combination of probiotics and plant extracts targeting adherent-invasive Escherichia coli associated with Crohn's disease.

Development of a combination of probiotics and plant extracts targeting adherent-invasive Escherichia coli associated with Crohn's disease.

Journal: Beneficial microbes

Published: March 10, 2025

ChiA: a major player in the virulence of Crohn's disease-associated adherent and invasive Escherichia coli (AIEC).

ChiA: a major player in the virulence of Crohn's disease-associated adherent and invasive Escherichia coli (AIEC).

Journal: Gut microbes

Published: October 14, 2024

Biochemical characterization of the Escherichia coli surfaceome: a focus on type I fimbriae and flagella.

Biochemical characterization of the Escherichia coli surfaceome: a focus on type I fimbriae and flagella.

Journal: Frontiers in microbiology

Published: October 07, 2024

Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn's disease patients.

Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn's disease patients.

Journal: Gut microbes

Published: September 29, 2022

An adherent-invasive Escherichia coli-colonized mouse model to evaluate microbiota-targeting strategies in Crohn's disease.

An adherent-invasive Escherichia coli-colonized mouse model to evaluate microbiota-targeting strategies in Crohn's disease.

Journal: Disease models & mechanisms

Published: June 30, 2022

Beneficial Effects of Linseed Supplementation on Gut Mucosa-Associated Microbiota in a Physically Active Mouse Model of Crohn's Disease.

Beneficial Effects of Linseed Supplementation on Gut Mucosa-Associated Microbiota in a Physically Active Mouse Model of Crohn's Disease.

Journal: International journal of molecular sciences

Published: April 22, 2022

Role of mucus-bacteria interactions in Enterotoxigenic Escherichia coli (ETEC) H10407 virulence and interplay with human microbiome.

Role of mucus-bacteria interactions in Enterotoxigenic Escherichia coli (ETEC) H10407 virulence and interplay with human microbiome.

Journal: NPJ biofilms and microbiomes

Published: March 31, 2022

In Vitro Evaluation of Dietary Fiber Anti-Infectious Properties against Food-Borne Enterotoxigenic Escherichia coli.

In Vitro Evaluation of Dietary Fiber Anti-Infectious Properties against Food-Borne Enterotoxigenic Escherichia coli.

Journal: Nutrients

Published: July 27, 2021

Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease.

Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease.

Journal: Microbiome

Published: April 27, 2021

Heteropolysaccharides from S. cerevisiae show anti-adhesive properties against E. coli associated with Crohn's disease.

Heteropolysaccharides from S. cerevisiae show anti-adhesive properties against E. coli associated with Crohn's disease.

Journal: Carbohydrate polymers

Published: March 26, 2021

The Role of OmpR in Bile Tolerance and Pathogenesis of Adherent-Invasive Escherichia coli.

The Role of OmpR in Bile Tolerance and Pathogenesis of Adherent-Invasive Escherichia coli.

Journal: Frontiers in microbiology

Published: March 23, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026